OCUL Ocular Therapeutix, Inc. - Common Stock
$11.43
价格 · 八月 19, 2026
截至...的财报数据 八月 3, 2026
52周区间
$6–$16
51% of range
分析师评级
BUY
18 analysts
目标价
$27
+137% upside
P/E (TTM)
-8.0
ROE
-55.4%
净利润率
-511.9%
OCUL 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$11.43
市值
$2.47B
P/E (TTM)
-8.0
每股收益 (TTM)
$-1.42
营收 (TTM)
$52M
股息收益率
—
ROE
-55.4%
负债/权益
—
52周区间
$6 – $16
OCUL 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$52M
2016-12-31
→
2025-12-31
EPS
$-1.42
2019-12-31
→
2025-12-31
自由现金流
$-217M
2016-12-31
→
2025-12-31
利润率
-511.9%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
OCUL
同行中位数
P/E (TTM)
-8.0
19.1
P/S (TTM) (市销率 (TTM))
47.5
14.2
P/B (市净率)
3.8
3.6
Price / FCF (股价/自由现金流)
-11.4
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
OCUL
同行中位数
Operating Margin (营业利润率)
-519.8%
—
Net Profit Margin (净利润率)
-511.9%
-4.3%
ROA
-42.0%
-2.9%
ROE
-55.4%
-6.8%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
OCUL
同行中位数
Current Ratio (流动比率)
15.4
4.7
Quick Ratio (速动比率)
15.1
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
OCUL
同行中位数
Revenue YoY (营收同比增长)
-18.5%
—
Revenue CAGR 3Y (营收3年复合年增长率)
0.29%
—
Revenue CAGR 5Y (营收5年复合年增长率)
24.4%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
OCUL
同行中位数
OCUL 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
18 位分析师
- 强烈买入 6 33.3%
- 买入 11 61.1%
- 持有 1 5.6%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
11 位分析师 · 2026-08-19
中位数
$28.00
← 低于所有目标
$11.43
最低
$18.00
最高
$34.00
中位数目标
$28.00
+145.0%
平均目标
$27.09
+137.0%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.02%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.35 | $-0.40 | 0.05% |
| 2026年3月31日 | $-0.40 | $-0.32 | -0.08% |
| 2025年12月31日 | $-0.29 | $-0.33 | 0.04% |
| 2025年9月30日 | $-0.38 | $-0.37 | -0.01% |
| 2025年6月30日 | $-0.39 | $-0.36 | -0.03% |
| 2025年3月31日 | $-0.38 | $-0.30 | -0.08% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | — |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | — |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | — |
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| RAPP | $1.45B | -10.6 | — | — | -29.8% | — |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $52M | $64M | $58M | $51M | $44M | $17M | $4M | $2M | $2M | $2M | $2M | $772.0K | |
| Cost of Revenue | $7M | $6M | $5M | $5M | $4M | $2M | $2M | $465.0K | $457.0K | $443.0K | $319.0K | $91.0K | |
| R&D Expense | $197M | $128M | $61M | $53M | $50M | $29M | $41M | $37M | $31M | $27M | $27M | $19M | |
| SG&A Expense | $64M | $61M | $34M | $32M | $32M | $23M | $22M | $19M | $16M | $11M | $9M | $7M | |
| Operating Expenses | $322M | $236M | $141M | $130M | $122M | $80M | $90M | $61M | $64M | $45M | $40M | $28M | |
| Operating Income | $-270M | $-172M | $-82M | $-79M | $-78M | $-63M | $-86M | $-59M | $-62M | $-43M | $-38M | $-27M | |
| Interest Expense | · | · | $11M | $7M | $7M | $7M | $6M | $2M | $2M | $2M | $2M | $1M | |
| Other Non-op | $4M | $-22M | $2M | $-1.0K | $1.0K | · | $-8.0K | · | $5.0K | $-1.0K | $7.0K | $-442.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-266M | $-194M | $-81M | $-71M | $-7M | $-156M | $-86M | $-60M | $-63M | $-45M | $-40M | $-29M | |
| EPS (Basic) | $-1.42 | $-1.22 | $-1.01 | $-0.92 | $-0.09 | $-2.56 | $-1.91 | · | · | · | · | · | |
| EPS (Diluted) | $-1.42 | $-1.22 | $-1.02 | $-0.97 | $-0.98 | $-2.56 | $-1.91 | · | · | · | · | · | |
| Shares (Basic) | 187,241,483 | 158,265,162 | 79,827,362 | 76,875,035 | 76,392,870 | 60,752,225 | 45,273,231 | · | · | · | · | · | |
| Shares (Diluted) | 187,241,483 | 158,265,162 | 85,596,594 | 82,644,267 | 82,162,102 | 60,752,225 | 45,273,231 | · | · | · | · | · | |
| EBITDA | $-266M | $-168M | $-79M | $-77M | $-76M | $-60M | $-83M | $-57M | $-60M | $-42M | $-37M | $-27M |
资产负债表 23
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $737M | $392M | $196M | $102M | $164M | $228M | $54M | $54M | $42M | $33M | $31M | $37M | |
| Receivables | $31M | $32M | $26M | $21M | $21M | $12M | $3M | $201.0K | $226.0K | $250.0K | $193.0K | $329.0K | |
| Inventory | $4M | $3M | $2M | $2M | $1M | $1M | $954.0K | $217.0K | $122.0K | $113.0K | $134.0K | $133.0K | |
| Prepaid Expense | $11M | $13M | $8M | $4M | $5M | $5M | $2M | $2M | $1M | $1M | $2M | $893.0K | |
| Current Assets | $782M | $441M | $232M | $130M | $191M | $246M | $60M | $56M | $43M | $70M | $107M | $76M | |
| PP&E (Net) | $20M | $9M | $12M | $10M | $7M | $8M | $10M | $10M | $10M | $3M | $3M | $2M | |
| PP&E (Gross) | $47M | $33M | $32M | $27M | $22M | $21M | $20M | $18M | $16M | $7M | $6M | $4M | |
| Accum. Depreciation | $28M | $24M | $20M | $17M | $15M | $13M | $10M | $8M | $5M | $4M | $3M | $2M | |
| Total Assets | $808M | $458M | $252M | $149M | $205M | $262M | $79M | $73M | $55M | $75M | $110M | $78M | |
| Accounts Payable | $4M | $4M | $4M | $5M | $5M | $3M | $3M | $3M | $4M | $2M | $2M | $1M | |
| Accrued Liabilities | $44M | $35M | $29M | $24M | $20M | $14M | $8M | $6M | $4M | $5M | $3M | $3M | |
| Short-term Debt | · | · | · | · | · | $8M | · | · | $6M | $2M | · | $1M | |
| Current Liabilities | $51M | $41M | $35M | $31M | $26M | $27M | $12M | $9M | $13M | $8M | $5M | $6M | |
| Capital Leases | $3M | $5M | $7M | $9M | $6M | $8M | $9M | · | · | · | · | · | |
| Other Non-current Liabilities | $887.0K | $141.0K | $108.0K | $93.0K | · | · | · | $3M | · | · | · | · | |
| Total Liabilities | $154M | $143M | $161M | $114M | $117M | $186M | $82M | $37M | $29M | $23M | $21M | $19M | |
| Total Debt | · | · | · | · | · | $8M | · | · | $6M | $2M | · | $1M | |
| Common Stock | $22.0K | $16.0K | $12.0K | $8.0K | $8.0K | $8.0K | $5.0K | $4.0K | $3.0K | $3.0K | $2.0K | $2.0K | |
| Retained Earnings | $-1.16B | $-891M | $-698M | $-617M | $-546M | $-539M | $-384M | $-297M | $-237M | $-174M | $-129M | $-89M | |
| AOCI | · | · | · | · | · | · | · | · | · | $-5.0K | $-68.0K | · | |
| Stockholders' Equity | $654M | $315M | $91M | $35M | $88M | $76M | $-4M | $36M | $26M | $52M | $90M | $59M | |
| Liabilities + Equity | $808M | $458M | $252M | $149M | $205M | $262M | $79M | $73M | $55M | $75M | $110M | $78M | |
| Shares Outstanding | 215,927,600 | 157,749,490 | 114,963,193 | 77,201,819 | 76,731,940 | 75,996,732 | 50,333,559 | 41,518,091 | 29,658,202 | 25,024,100 | 24,750,281 | 21,333,507 |
现金流 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $881.0K | $754.0K | $547.0K | |
| Stock-based Comp | $43M | $33M | $18M | $17M | $15M | $8M | $9M | $7M | $7M | $6M | $5M | $3M | |
| Restructuring | · | · | · | · | · | · | $3M | · | $3M | · | · | · | |
| Other Non-cash | $14M | $22M | $-10M | $-8M | $-76M | $92M | $-2M | $982.0K | $4M | $4M | $611.0K | $5M | |
| Operating Cash Flow | $-205M | $-135M | $-70M | $-60M | $-66M | $-54M | $-78M | $-49M | $-50M | $-34M | $-34M | $-20M | |
| CapEx | $12M | $1M | $6M | $4M | $1M | $841.0K | $2M | $2M | $8M | $2M | $2M | $1M | |
| Investing Cash Flow | $-12M | $-1M | $-6M | $-4M | $-1M | $-841.0K | $-2M | $-2M | $27M | $37M | $-39M | · | |
| Debt Issued | · | · | $82M | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | $117M | · | · | $225M | $38M | $62M | $29M | $627.0K | $66M | $70M | |
| Net Stock Activity | · | · | $117M | · | · | $225M | $38M | $62M | $29M | $872.0K | · | $70M | |
| Financing Cash Flow | $562M | $332M | $170M | $1M | $3M | $228M | $75M | $69M | $32M | $585.0K | $66M | · | |
| Net Change in Cash | $345M | $196M | $94M | $-62M | $-64M | $174M | $-4M | $18M | $8M | $4M | $-7M | $20M | |
| Free Cash Flow | $-217M | $-136M | $-76M | $-63M | $-67M | $-54M | $-80M | $-51M | $-59M | $-36M | $-36M | $-22M |
盈利能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -519.8% | -269.6% | -141.0% | -152.7% | -179.3% | -361.1% | -2029.9% | -2970.8% | -3220.1% | -2296.0% | -2182.7% | -3509.6% | |
| Net Margin | -511.9% | -303.7% | -138.1% | -137.9% | -15.1% | -894.3% | -2043.3% | -3014.0% | -3296.2% | -2369.0% | -2271.3% | -3710.9% | |
| EBITDA Margin | -511.4% | -263.6% | -135.9% | -148.7% | -173.7% | -345.2% | -1970.0% | -2855.9% | -3135.6% | -2249.3% | -2139.6% | -3438.7% | |
| ROA | -42.0% | -54.5% | -40.2% | -40.1% | -2.8% | -91.4% | -113.8% | -93.4% | -97.2% | -48.3% | -42.2% | -58.9% | |
| ROE | -55.4% | -58.0% | -163.1% | -174.1% | -7.5% | -432.5% | -2251.9% | -147.4% | -162.2% | -63.1% | -53.6% | 7383.5% |
流动性与偿付能力 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 15.4 | 10.7 | 6.7 | 4.1 | 7.3 | 9.2 | 5.0 | 6.1 | 3.2 | 8.4 | 19.9 | 13.0 | |
| Quick Ratio | 15.1 | 10.3 | 6.4 | 3.9 | 7.0 | 9.0 | 4.7 | 5.9 | 3.1 | 4.0 | 5.8 | 6.4 | |
| Debt / Equity | · | · | · | · | · | 0.1 | · | · | 0.2 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | -7.3 | -11.2 | -11.7 | -9.3 | -14.1 | -34.0 | -32.7 | -25.8 | -22.2 | -24.2 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | 0.3 | 0.3 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 2.0 | 2.1 | 2.5 | 2.8 | 3.6 | 1.9 | 4.0 | · | 3.9 | 3.6 | 2.4 | 1.4 | |
| Receivables Turnover | 1.6 | 2.2 | 2.5 | 2.4 | 2.6 | 2.4 | 3.1 | 9.3 | 8.1 | 8.5 | 6.7 | 2.7 |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -18.5% | 9.0% | 13.5% | 18.3% | 150.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.29% | 13.6% | 49.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 24.4% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $52M | $64M | $58M | $51M | $44M | $17M | $4M | $2M | $2M | $2M | $2M | $772.0K | |
| Net Income TTM | $-266M | $-194M | $-81M | $-71M | $-7M | $-156M | $-86M | $-60M | $-63M | $-45M | $-40M | $-29M | |
| Market Cap | $2.62B | $1.35B | $513M | $217M | $535M | $1.57B | $199M | $165M | $132M | $209M | $232M | $502M | |
| Enterprise Value | · | · | · | · | · | $1.35B | · | · | $96M | $178M | · | $466M | |
| P/E | -8.5 | -7.0 | -4.4 | -2.9 | -7.1 | -8.1 | -2.1 | -2.5 | · | · | · | · | |
| P/S | 50.5 | 21.1 | 8.8 | 4.2 | 12.3 | 90.4 | 47.0 | 83.0 | 68.6 | 111.0 | 132.5 | 650.0 | |
| P/B | 4.0 | 4.3 | 5.6 | 6.1 | 6.1 | 20.7 | -54.8 | 4.6 | 5.0 | 4.0 | 2.6 | 8.5 | |
| P / Tangible Book | 4.0 | 4.3 | 5.6 | 6.1 | 6.1 | 20.7 | · | · | · | · | · | · | |
| P / Cash Flow | -12.8 | -10.0 | -7.3 | -3.6 | -8.2 | -29.4 | -2.6 | -3.4 | -2.6 | -6.2 | -6.9 | -24.5 | |
| P / FCF | -12.1 | -9.9 | -6.7 | -3.4 | -8.0 | -28.9 | -2.5 | -3.2 | -2.2 | -5.8 | -6.5 | -23.1 | |
| EV / EBITDA | · | · | · | · | · | -22.5 | · | · | -1.6 | -4.2 | · | -17.5 | |
| EV / FCF | · | · | · | · | · | -24.9 | · | · | -1.6 | -5.0 | · | -21.4 | |
| EV / Revenue | · | · | · | · | · | 77.8 | · | · | 49.9 | 94.4 | · | 603.3 | |
| Earnings Yield | -11.7% | -14.3% | -22.9% | -34.5% | -14.1% | -12.4% | -48.4% | -39.5% | · | · | · | · |
损益表 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13M | $11M | $13M | $15M | $13M | $11M | $17M | $15M | $16M | $15M | $15M | $15M | $15M | $13M | $14M | $12M | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| R&D Expense | $54M | $66M | $51M | $52M | $51M | $43M | $41M | $37M | $29M | $21M | $16M | $15M | $15M | $15M | $14M | $14M | |
| SG&A Expense | $22M | $20M | $18M | $16M | $14M | $16M | $15M | $12M | $20M | $14M | $8M | $9M | $8M | $9M | $8M | $9M | |
| Operating Expenses | $96M | $104M | $83M | $83M | $81M | $75M | $68M | $61M | $60M | $46M | $35M | $34M | $36M | $36M | $33M | $34M | |
| Operating Income | $-82M | $-93M | $-70M | $-69M | $-68M | $-64M | $-51M | $-46M | $-44M | $-32M | $-20M | $-19M | $-21M | $-23M | $-19M | $-22M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $3M | $2M | $2M | · | $2M | |
| Other Non-op | $3M | $5M | $5M | $-720.0K | $-173.0K | $-136.0K | $2M | $10M | $-187.0K | $-33M | $2M | $0 | $0 | $-1.0K | $0 | $1.0K | |
| Net Income | $-79M | $-89M | $-65M | $-69M | $-68M | $-64M | $-48M | $-36M | $-44M | $-65M | $-29M | $-516.0K | $-21M | $-30M | $-16M | $-24M | |
| EPS (Basic) | $-0.35 | $-0.40 | $-0.27 | $-0.38 | $-0.39 | $-0.38 | $-0.25 | $-0.22 | $-0.26 | $-0.49 | $-0.35 | $-0.01 | $-0.26 | $-0.39 | $-0.21 | $-0.31 | |
| EPS (Diluted) | $-0.35 | $-0.40 | $-0.27 | $-0.38 | $-0.39 | $-0.38 | $-0.25 | $-0.22 | $-0.26 | $-0.49 | $-0.12 | $-0.25 | $-0.26 | $-0.39 | $-0.19 | $-0.31 | |
| Shares (Basic) | 224,952,428 | 224,099,410 | -338,669,976 | 183,919,808 | 172,594,662 | 169,396,989 | -306,574,296 | 166,992,735 | 165,824,778 | 132,021,945 | -154,979,902 | 79,373,272 | 78,047,705 | 77,386,287 | -153,610,763 | 76,975,839 | |
| Shares (Diluted) | 224,952,428 | 224,099,410 | -338,669,976 | 183,919,808 | 172,594,662 | 169,396,989 | -306,574,296 | 166,992,735 | 165,824,778 | 132,021,945 | -154,979,902 | 85,142,504 | 78,047,705 | 77,386,287 | -159,379,995 | 76,975,839 | |
| EBITDA | $-82M | $-92M | · | $-69M | $-68M | $-63M | · | $-46M | $-44M | $-31M | · | $-19M | $-21M | $-22M | · | $-22M |
资产负债表 22
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $599M | $667M | $737M | $345M | $391M | $350M | $392M | $427M | $460M | $483M | $196M | $111M | $67M | $79M | $102M | $121M | |
| Receivables | $30M | $24M | $31M | $31M | $30M | $25M | $32M | $30M | $30M | $27M | · | $24M | $27M | $21M | · | $20M | |
| Inventory | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | · | $2M | $2M | $2M | · | $2M | |
| Prepaid Expense | $12M | $11M | $11M | $8M | $9M | $10M | $13M | $13M | $6M | $8M | · | $5M | $5M | $5M | · | $3M | |
| Current Assets | $644M | $706M | $782M | $387M | $433M | $388M | $441M | $473M | $499M | $520M | · | $141M | $101M | $107M | · | $146M | |
| PP&E (Net) | $19M | $18M | $20M | $17M | $10M | $11M | $9M | $10M | $11M | $11M | · | $12M | $13M | $12M | · | $7M | |
| PP&E (Gross) | · | · | $47M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $28M | · | · | · | $24M | · | · | · | · | · | · | · | · | · | |
| Total Assets | $671M | $733M | $808M | $411M | $451M | $406M | $458M | $490M | $517M | $539M | · | $162M | $123M | $129M | · | $159M | |
| Accounts Payable | $7M | $8M | $4M | $6M | $6M | $5M | $4M | $4M | $4M | $6M | · | $4M | $4M | $5M | · | $5M | |
| Accrued Liabilities | $39M | $36M | $44M | $40M | $34M | $31M | $35M | $30M | $24M | $16M | · | $29M | $25M | $22M | · | $22M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | · | · | |
| Current Liabilities | $49M | $48M | $51M | $49M | $43M | $38M | $41M | $36M | $30M | $24M | · | $35M | $32M | $30M | · | $29M | |
| Capital Leases | $3M | $4M | $3M | $4M | $4M | $5M | $5M | $6M | $6M | $6M | · | $7M | $8M | $8M | · | $5M | |
| Other Non-current Liabilities | $931.0K | $909.0K | $887.0K | $151.0K | $148.0K | $144.0K | $141.0K | $117.0K | $114.0K | $111.0K | · | $106.0K | $104.0K | $100.0K | · | · | |
| Total Liabilities | $151M | $151M | $154M | $153M | $145M | $140M | $143M | $138M | $139M | $131M | · | $155M | $119M | $119M | · | $112M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | · | · | |
| Common Stock | $22.0K | $22.0K | $22.0K | $18.0K | $17.0K | $16.0K | $16.0K | $16.0K | $16.0K | $15.0K | · | $8.0K | $8.0K | $8.0K | · | $8.0K | |
| Retained Earnings | $-1.32B | $-1.25B | $-1.16B | $-1.09B | $-1.02B | $-955M | $-891M | $-843M | $-806M | $-762M | · | $-668M | $-668M | $-647M | · | $-601M | |
| Stockholders' Equity | $520M | $582M | $654M | $258M | $306M | $266M | $315M | $352M | $378M | $408M | $91M | $8M | $3M | $10M | $35M | $46M | |
| Liabilities + Equity | $671M | $733M | $808M | $411M | $451M | $406M | $458M | $490M | $517M | $539M | · | $162M | $123M | $129M | · | $159M | |
| Shares Outstanding | 219,589,303 | 218,896,915 | 215,927,600 | 174,949,558 | 172,925,389 | 159,262,024 | 157,749,490 | 156,654,938 | 155,624,363 | 154,704,086 | · | 79,412,114 | 79,233,804 | 77,516,638 | · | 77,010,385 |
现金流 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $1M | $1M | $1M | $1M | $981.0K | $951.0K | $959.0K | $956.0K | $920.0K | $958.0K | $890.0K | $652.0K | $483.0K | $491.0K | $509.0K | |
| Stock-based Comp | $15M | $16M | $11M | $12M | $10M | $10M | $7M | $7M | $11M | $8M | $4M | $5M | $4M | $5M | $4M | $4M | |
| Restructuring | · | · | · | · | · | · | · | · | $2M | · | · | · | · | · | · | · | |
| Other Non-cash | · | $6M | · | · | · | $8M | · | · | · | $22M | · | · | · | $5M | · | · | |
| Operating Cash Flow | $-67M | $-66M | $-54M | $-51M | $-55M | $-45M | $-39M | $-37M | $-25M | $-34M | $-22M | $-8M | $-20M | $-20M | $-17M | $-13M | |
| CapEx | $3M | $5M | $3M | $6M | $1M | $2M | $202.0K | $89.0K | $742.0K | $255.0K | $459.0K | $259.0K | $2M | $3M | $2M | $794.0K | |
| Investing Cash Flow | $-3M | $-5M | $-3M | $-6M | $-1M | $-2M | $-202.0K | $-89.0K | $-742.0K | $-255.0K | $-459.0K | $-259.0K | $-2M | $-3M | $-2M | $-794.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $316M | · | $708.0K | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $316M | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $294.0K | $449M | $10M | $98M | $4M | $5M | $4M | $2M | $321M | $108M | $52M | $10M | $78.0K | $458.0K | $374.0K | |
| Net Change in Cash | $-68M | $-70M | $392M | $-46M | $41M | $-42M | $-35M | $-32M | $-23M | $287M | $85M | $44M | $-12M | $-23M | $-19M | $-14M | |
| Free Cash Flow | · | $-71M | · | · | · | $-47M | · | · | · | $-34M | · | · | · | $-23M | · | · |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -609.3% | -865.5% | · | -472.3% | -502.6% | -597.5% | · | -298.2% | -265.1% | -214.0% | · | -127.4% | -135.5% | -168.6% | · | -180.1% | |
| Net Margin | -584.5% | -821.6% | · | -477.3% | -503.9% | -598.7% | · | -236.6% | -266.3% | -438.9% | · | -3.4% | -136.2% | -226.7% | · | -202.2% | |
| EBITDA Margin | -609.3% | -853.6% | · | -472.3% | -502.6% | -588.3% | · | -298.2% | -265.1% | -207.8% | · | -127.4% | -135.5% | -165.0% | · | -180.1% | |
| ROA | -14.0% | -15.6% | · | -15.4% | -14.0% | -13.6% | · | -11.2% | -13.7% | -19.4% | · | -0.32% | -14.0% | -19.2% | · | -12.9% | |
| ROE | -19.1% | -20.9% | · | -22.8% | -19.8% | -19.0% | · | -20.3% | -23.0% | -31.1% | · | -1.9% | -60.0% | -67.8% | · | -36.2% |
流动性与偿付能力 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.1 | 14.8 | · | 7.9 | 10.1 | 10.2 | · | 13.0 | 16.6 | 21.4 | · | 4.0 | 3.1 | 3.6 | · | 5.0 | |
| Quick Ratio | 12.8 | 14.5 | · | 7.6 | 9.8 | 9.9 | · | 12.6 | 16.3 | 21.0 | · | 3.8 | 2.9 | 3.4 | · | 4.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | 0.7 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -7.8 | · | -5.6 | -10.3 | -12.8 | · | -12.0 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.6 | 0.4 | · | 0.6 | 0.7 | 0.4 | · | 0.7 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.7 | · | 0.8 | |
| Receivables Turnover | 0.4 | 0.4 | · | 0.5 | 0.4 | 0.4 | · | 0.6 | 0.6 | 0.6 | · | 0.7 | 0.6 | 0.6 | · | 0.6 |
估值 (TTM) 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $52M | $49M | · | $54M | $56M | $57M | · | $62M | $61M | $58M | · | $56M | $53M | $51M | · | $50M | |
| Net Income TTM | $-305M | $-290M | · | $-238M | $-212M | $-209M | · | $-146M | $-130M | $-116M | · | $-76M | $-94M | $-86M | · | $-53M | |
| Market Cap | $2.16B | $1.85B | · | $2.05B | $1.60B | $1.17B | · | $1.36B | $1.06B | $1.41B | · | $249M | $409M | $409M | · | $320M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | $344M | · | · | · | |
| P/E | -6.5 | -5.5 | · | -8.5 | -7.4 | -5.4 | · | -7.1 | -5.4 | -6.5 | · | -2.6 | -4.3 | -4.5 | · | -4.1 | |
| P/S | 41.3 | 37.5 | · | 37.8 | 28.6 | 20.4 | · | 22.1 | 17.3 | 24.1 | · | 4.5 | 7.7 | 8.0 | · | 6.4 | |
| P/B | 4.1 | 3.2 | · | 7.9 | 5.2 | 4.4 | · | 3.9 | 2.8 | 3.5 | · | 31.8 | 132.4 | 42.1 | · | 6.9 | |
| P / Tangible Book | 4.1 | 3.2 | · | 7.9 | 5.2 | 4.4 | · | 3.9 | 2.8 | 3.5 | · | 31.8 | 132.4 | 42.1 | · | 6.9 | |
| P / Cash Flow | · | -28.1 | · | · | · | -26.1 | · | · | · | -41.5 | · | · | · | -20.5 | · | · | |
| P / FCF | · | -26.2 | · | · | · | -25.0 | · | · | · | -41.2 | · | · | · | -17.5 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | -16.7 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | 6.5 | · | · | · | |
| Earnings Yield | -15.5% | -18.3% | · | -11.7% | -13.5% | -18.4% | · | -14.0% | -18.4% | -15.3% | · | -38.5% | -23.4% | -22.2% | · | -24.3% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $52M | $64M | $58M | $51M | $44M |
| 营业利润率 % | -519.8% | -269.6% | -141.0% | -152.7% | -179.3% |
| 净收入 | $-266M | $-194M | $-81M | $-71M | $-7M |
| 稀释后每股收益 (EPS) | $-1.42 | $-1.22 | $-1.02 | $-0.97 | $-0.98 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 15.4 | 10.7 | 6.7 | 4.1 | 7.3 |
| 速动比率 | 15.1 | 10.3 | 6.4 | 3.9 | 7.0 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-217M | $-136M | $-76M | $-63M | $-67M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 287 家申报者 · $1.5B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 41 (-43 与上一季度对比) | 40 (-8 与上一季度对比) | 92 (-17 与上一季度对比) | 85 (+27 与上一季度对比) | -3.7M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Deep Track Capital, LP | $193319289 | 19686282 | 12.74% | 股份 |
| FMR LLC | $186253151 | 18966716 | 12.28% | 股份 |
| Avoro Capital Advisors LLC | $123142800 | 12540000 | 8.12% | 股份 |
| Summer Road LLC | $119885466 | 12208296 | 7.90% | 股份 |
| Venrock Adviser, LLC | $101606813 | 10346926 | 6.70% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $86736083 | 8832595 | 5.72% | 股份 |
| Logos Global Management LP | $52046000 | 5300000 | 3.43% | 股份 |
| STATE STREET CORP | $51390829 | 5233282 | 3.39% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $42555901 | 4332781 | 2.81% | 股份 |
| Point72 Asset Management, L.P. | $32329335 | 3292193 | 2.13% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $25633686 | 2610355 | 1.69% | 股份 |
| Balyasny Asset Management L.P. | $22298343 | 2270707 | 1.47% | 股份 |
| Octagon Capital Advisors LP | $20376500 | 2075000 | 1.34% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $19376137 | 1973130 | 1.28% | 股份 |
| Woodline Partners LP | $16375920 | 1667609 | 1.08% | 股份 |
| TCG Crossover Management, LLC | $16180925 | 1647752 | 1.07% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $15221000 | 1550000 | 1.00% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $15058361 | 1533438 | 0.99% | 股份 |
| Defilade Capital Management, L.P. | $14634609 | 1490286 | 0.96% | 股份 |
| GOLDMAN SACHS GROUP INC | $13918348 | 1417347 | 0.92% | 股份 |
| Squarepoint Ops LLC | $13904266 | 1415913 | 0.92% | 股份 |
| Boxer Capital Management, LLC | $12766000 | 1300000 | 0.84% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $12659944 | 1289200 | 0.83% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $11965798 | 1218513 | 0.79% | 股份 |
| Knoll Capital Management, LLC | $11296928 | 1150400 | 0.74% | 股份 |
| UBS Group AG | $11278476 | 1148521 | 0.74% | 股份 |
| Balyasny Asset Management L.P. | $9576464 | 975200 | 0.63% | 买入期权 |
| Candriam S.C.A. | $8906402 | 907839 | 0.59% | 股份 |
| Empire Life Investments Inc. | $8560015 | 871692 | 0.56% | 股份 |
| Cetera Investment Advisers | $7715885 | 785732 | 0.51% | 股份 |
| PEREGRINE CAPITAL MANAGEMENT LLC | $7399321 | 753495 | 0.49% | 股份 |
| Aptus Capital Advisors, LLC | $6271946 | 638691 | 0.41% | 股份 |
| Second Line Capital, LLC | $6271445 | 638640 | 0.41% | 股份 |
| BlackRock, Inc. | $6216905 | 633086 | 0.41% | 股份 |
| Opaleye Management Inc. | $5892000 | 600000 | 0.39% | 股份 |
| ALGERT GLOBAL LLC | $5816474 | 592309 | 0.38% | 股份 |
| Cubist Systematic Strategies, LLC | $5449633 | 466179 | 0.36% | 股份 |
| Man Group plc | $5337975 | 543582 | 0.35% | 股份 |
| Sio Capital Management, LLC | $5297821 | 539493 | 0.35% | 股份 |
| ACUTA CAPITAL PARTNERS, LLC | $5228963 | 532481 | 0.34% | 股份 |
| AXA Investment Managers S.A. | $5142209 | 439881 | 0.34% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $5132551 | 522663 | 0.34% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4754058 | 484120 | 0.31% | 股份 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $4734752 | 482154 | 0.31% | 股份 |
| BEACON INVESTMENT ADVISORS LLC | $4272986 | 435131 | 0.28% | 股份 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $4131461 | 420719 | 0.27% | 股份 |
| Trexquant Investment LP | $4112429 | 418781 | 0.27% | 股份 |
| HighVista Strategies LLC | $4011804 | 408534 | 0.26% | 股份 |
| Rock Springs Capital Management LP | $3768091 | 383716 | 0.25% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $3719364 | 378754 | 0.25% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $3710251 | 377826 | 0.24% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3627508 | 369400 | 0.24% | 买入期权 |
| Propel Bio Management, LLC | $3515226 | 357966 | 0.23% | 股份 |
| CITADEL ADVISORS LLC | $3440928 | 350400 | 0.23% | 买入期权 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3296240 | 335666 | 0.22% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $3033427 | 308903 | 0.20% | 股份 |
| Swiss National Bank | $3002956 | 305800 | 0.20% | 股份 |
| KVP Capital Advisors, LP | $2946000 | 300000 | 0.19% | 股份 |
| Verition Fund Management LLC | $2938134 | 299199 | 0.19% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2859584 | 291200 | 0.19% | 卖出期权 |
| RHUMBLINE ADVISERS | $2657690 | 270642 | 0.18% | 股份 |
| E. Ohman J:or Asset Management AB | $2541000 | 300000 | 0.17% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2436000 | 248048 | 0.16% | 股份 |
| BARCLAYS PLC | $2429400 | 247393 | 0.16% | 股份 |
| Advisory Services Network, LLC | $2262852 | 230433 | 0.15% | 股份 |
| TD Asset Management Inc | $2256636 | 229800 | 0.15% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2251294 | 229256 | 0.15% | 股份 |
| Rhenman & Partners Asset Management AB | $2209500 | 225000 | 0.15% | 股份 |
| ORBIMED ADVISORS LLC | $2160400 | 220000 | 0.14% | 股份 |
| BANK OF AMERICA CORP /DE/ | $2036531 | 207386 | 0.13% | 股份 |
| Walleye Capital LLC | $1981499 | 201782 | 0.13% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $1922859 | 227020 | 0.13% | 股份 |
| Bank of New York Mellon Corp | $1869404 | 190367 | 0.12% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1856814 | 187557 | 0.12% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $1830016 | 186356 | 0.12% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1810090 | 213706 | 0.12% | 股份 |
| Exome Asset Management LLC | $1783194 | 181588 | 0.12% | 股份 |
| TWO SIGMA ADVISERS, LP | $1735097 | 142924 | 0.11% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $1683148 | 171400 | 0.11% | 买入期权 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1660209 | 169064 | 0.11% | 股份 |
| Steward Partners Investment Advisory, LLC | $1621694 | 165142 | 0.11% | 股份 |
| Wealthspire Advisors, LLC | $1600267 | 162960 | 0.11% | 股份 |
| CITADEL ADVISORS LLC | $1519154 | 154700 | 0.10% | 卖出期权 |
| WESBANCO BANK INC | $1463180 | 149000 | 0.10% | 股份 |
| RoundAngle Advisors LLC | $1410119 | 166484 | 0.09% | 股份 |
| SIMPLEX TRADING, LLC | $1338033 | 136256 | 0.09% | 股份 |
| VANGUARD GROUP INC | $1266955 | 104362 | 0.08% | 股份 |
| CITIGROUP INC | $1265160 | 128835 | 0.08% | 股份 |
| D. E. Shaw & Co., Inc. | $1222168 | 124457 | 0.08% | 股份 |
| Marble Bar Asset Management LLP | $1203127 | 122518 | 0.08% | 股份 |
| TRUIST FINANCIAL CORP | $1188220 | 121000 | 0.08% | 股份 |
| MetLife Investment Management, LLC | $1178724 | 120033 | 0.08% | 股份 |
| JPMORGAN CHASE & CO | $1103781 | 111493 | 0.07% | 股份 |
| Vontobel Holding Ltd. | $1093634 | 111368 | 0.07% | 股份 |
| Erste Asset Management GmbH | $1089000 | 110000 | 0.07% | 股份 |
| KRAEMATON INVESTMENT ADVISORS, INC | $1079876 | 109967 | 0.07% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $1078491 | 109826 | 0.07% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $1024835 | 104362 | 0.07% | 股份 |
| J. Goldman & Co LP | $999283 | 101760 | 0.07% | 股份 |
| XTX Topco Ltd | $996445 | 101471 | 0.07% | 股份 |
公司内部人士 36 位内幕人士 · 25 位高管 · 13 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Dugel Pravin | Executive Chairman, President and CEO | 2026年6月16日 G | 50092 | 0 | 5 | $-1962405 |
| Antony C. Mattessich | President and CEO | 2024年2月3日 A | 588701 | 0 | 0 | $0 |
| Jason Shand Robins | Chief Financial Officer | 2026年6月10日 A | 68097 | 0 | 0 | $0 |
| Bradford W Smith | CFO and Treasurer | 2017年1月31日 A | — | 0 | 0 | $0 |
| Michael H. Goldstein | President, Ophthalmology & CMO | 2022年2月3日 A | 313335 | 0 | 0 | $0 |
| Donald Notman | Chief Operating Officer | 2026年2月12日 S | 366356 | 0 | 4 | $-218120 |
| Patricia Kitchen | Chief Operating Officer | 2021年2月17日 A | — | 0 | 0 | $0 |
| James Fortune | Chief Operating Officer | 2017年1月31日 A | 112060 | 0 | 0 | $0 |
| Nadia Waheed | Chief Medical Officer | 2026年6月3日 S | 300079 | 0 | 3 | $-220877 |
| Sanjay Nayak | Chief Strategy Officer | 2026年5月26日 S | 328795 | 0 | 5 | $-168653 |
| Peter Kaiser | Chief Development Officer | 2026年5月26日 S | 266141 | 0 | 5 | $-226465 |
| Jeffrey S. Heier | Chief Scientific Officer | 2026年5月26日 S | 320350 | 0 | 5 | $-244648 |
| David Wayne Robinson | Global CCO | 2026年1月21日 A | 136000 | 0 | 0 | $0 |
| Steve Lawrence Meyers | Chief Commercial Officer | 2026年1月2日 A | 217628 | 0 | 0 | $0 |
| Namrata Saroj | Chief Business Officer | 2026年1月2日 A | 254620 | 0 | 1 | $-277790 |
| Todd Anderman | Chief Legal Officer | 2026年1月2日 A | 152468 | 0 | 1 | $-137369 |
| Philip C. Strassburger | General Counsel | 2024年2月3日 A | 161493 | 0 | 0 | $0 |
| Rabia Gurses Ozden | Chief Medical Officer | 2024年2月3日 A | 153054 | 0 | 0 | $0 |
| Christopher G White | Chief Business Officer | 2024年2月3日 A | 123689 | 0 | 0 | $0 |
| Amarpreet Sawhney | Chairman of the Board | 2019年6月7日 P | 1056031 | 0 | 0 | $0 |
| Kevin F. Hanley | Sr. VP Technical Operations | 2019年1月2日 A | 20000 | 0 | 0 | $0 |
| Daniel M Bollag | Sr. VP Reg. Affairs & Quality | 2019年1月2日 A | 42100 | 0 | 0 | $0 |
| Charles Andrew Hurley | Chief Commercial Officer | 2017年1月31日 A | — | 0 | 0 | $0 |
| Jonathan H. Talamo | Chief Medical Officer | 2017年1月31日 A | — | 0 | 0 | $0 |
| Eric Ankerud | EVP, Regulatory, Quality & Compliance | 2017年1月31日 A | 78651 | 0 | 0 | $0 |
| Seung Suh Hong | 董事 | 2026年6月10日 A | 60933 | 0 | 0 | $0 |
| Leslie J. Williams | 董事 | 2026年6月10日 A | 65433 | 0 | 0 | $0 |
| Charles M Warden | 董事 | 2026年6月10日 A | 100464 | 0 | 0 | $0 |
| Adrienne L Graves | 董事 | 2026年6月10日 A | 64000 | 0 | 0 | $0 |
| Richard L Lindstrom MD | 董事 | 2026年6月10日 A | 260933 | 1 | 0 | $461354 |
| RAINES MERILEE | 董事 | 2026年6月10日 A | 60933 | 0 | 0 | $0 |
| Bruce Peacock | 董事 | 2021年6月18日 A | 0 | 0 | 0 | $0 |
| Jaswinder Chadha | 董事 | 2018年6月14日 A | 130448 | 0 | 0 | $0 |
| William J Oshea | 董事 | 2018年6月14日 A | — | 0 | 0 | $0 |
| James M Garvey | 董事 | 2017年6月1日 A | — | 0 | 0 | $0 |
| SUMMER ROAD LLC | 10% 所有者 | 2024年2月26日 P | 8591401 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Summer Road LLC ×6 申报 | 2024年2月27日 | — | 初始申报 | 被动投资 | SEC |
| Amarpreet Sawhney | 2014年8月4日 | — | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 40 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1.32% | 18162 NS | 2026年4月30日 | N-PORT |
| BIB · ProShares Trust | 0.10% | 8049 NS | 2026年5月31日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.08% | 65684 NS | 2026年4月30日 | N-PORT |
| RSSL · Global X Funds | 0.05% | 81474 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.04% | 8848 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.04% | 528156 NS | 2026年4月30日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.03% | 842934 NS | 2026年5月31日 | N-PORT |
| UWM · ProShares Trust | 0.03% | 6920 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 72719 NS | 2026年4月30日 | N-PORT |
| URTY · ProShares Trust | 0.02% | 6998 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 7543 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 176 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 71876 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 17163 NS | 2026年4月30日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 184477 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 99636 NS | 2026年5月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 24811 NS | 2026年4月30日 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 3657 NS | 2026年4月30日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 31811 NS | 2026年4月30日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 449 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| ITOT · iShares Trust | — | — | 2026年8月5日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWN · iShares Trust | — | — | 2026年8月17日 | 每日 |
| IWO · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IHE · iShares Trust | — | — | 2026年8月18日 | 每日 |
| PJP · Invesco Exchange-Traded Fund Trust | — | — | 2026年8月6日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026年7月13日 | 每日 |
| VHT · VANGUARD WORLD FUND | — | — | 2026年7月20日 | 每日 |
| ISCB · iShares Trust | — | — | 2026年8月5日 | 每日 |
| ISCG · iShares Trust | — | — | 2026年8月5日 | 每日 |
| ISCV · iShares Trust | — | — | 2026年8月5日 | 每日 |
| WSML · iShares Trust | — | — | 2026年8月5日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | — | — | 2026年7月20日 | 每日 |